US pharmaceutical giant Pfizer has offered what it said would be its bid to acquire UK rival AstraZeneca, but its $119 billion proposal was turned down.
Reports say AstraZeneca rejected the bid just hours after it was introduced by Pfizer, despite Pfizer’s deadline for AstraZeneca to respond to the bid by …read more
Source: Global Competition Law Blogs